{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:57:05Z","timestamp":1786978625091,"version":"build-2736575974"},"publisher-location":"Cham","reference-count":194,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030573775","type":"print"},{"value":"9783030573782","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_314","type":"book-chapter","created":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T02:02:51Z","timestamp":1581127371000},"page":"93-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Thyroid Hormones, Glucocorticoids, Insulin, and Bone"],"prefix":"10.1007","author":[{"given":"Peter","family":"Lakatos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Szili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bence","family":"Bakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Takacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Putz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Istenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,9]]},"reference":[{"issue":"9","key":"314_CR1","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/jbmr.2244","volume":"29","author":"B Abrahamsen","year":"2014","unstructured":"Abrahamsen B, Jorgensen HL, Laulund AS, Nybo M, Brix TH, Hegedus L (2014) Low serum thyrotropin level and duration of suppression as a predictor of major osteoporotic fractures-the OPENTHYRO register cohort. J Bone Miner Res 29(9):2040\u20132050. https:\/\/doi.org\/10.1002\/jbmr.2244","journal-title":"J Bone Miner Res"},{"issue":"1","key":"314_CR2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","volume":"44","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Saag KG, Delmas PD et al (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo controlled extension trial. Arthritis Rheum 44(1):202\u2013211","journal-title":"Arthritis Rheum"},{"issue":"5","key":"314_CR3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1185\/03007990902801147","volume":"25","author":"S Adami","year":"2009","unstructured":"Adami S (2009) Bone health in diabetes: considerations for clinical management. Curr Med Res Opin 25(5):1057\u20131072","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"314_CR4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/joe.0.1330327","volume":"133","author":"TJ Allain","year":"1992","unstructured":"Allain TJ, Chambers TJ, Flanagan AM, McGregor AM (1992) Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect. J Endocrinol 133(3):327\u2013331","journal-title":"J Endocrinol"},{"issue":"5","key":"314_CR5","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-015-3455-9","volume":"27","author":"MA Amiche","year":"2016","unstructured":"Amiche MA, Albaum JM, Tadrous M et al (2016) Fracture risk in oral glucocorticoid users: a Bayesian metaregression leveraging control arms of osteoporosis clinical trials. Osteoporos Int 27(5):1709\u20131718","journal-title":"Osteoporos Int"},{"issue":"1","key":"314_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00198-016-3844-8","volume":"28","author":"T An","year":"2017","unstructured":"An T, Hao J, Sun S, Li R, Yang M, Cheng G, You M (2017) Efficacy of statins for osteoporosis: a systematic review and meta-analysis. Osteoporos Int 28(1):47\u201357","journal-title":"Osteoporos Int"},{"issue":"3","key":"314_CR7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cmet.2015.06.010","volume":"22","author":"AP Arruda","year":"2015","unstructured":"Arruda AP, Hotamisligil GS (2015) Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes. Cell Metab 22(3):381\u2013397","journal-title":"Cell Metab"},{"key":"314_CR8","doi-asserted-by":"publisher","unstructured":"Aung K, Htay T (2011) Thiazide diuretics and the risk of hip fracture. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005185.pub2","DOI":"10.1002\/14651858.CD005185.pub2"},{"key":"314_CR9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2337\/diacare.19.12.1388","volume":"19","author":"E Baerrett-Connor","year":"1996","unstructured":"Baerrett-Connor E, Kritz-Silverstein D (1996) Does hyperinsulinemia preserve bone? Diabetes Care 19:1388\u20131392","journal-title":"Diabetes Care"},{"issue":"9","key":"314_CR10","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1359\/jbmr.1999.14.9.1550","volume":"14","author":"R Ballock","year":"1999","unstructured":"Ballock R, Mita BC, Zhou X, Chen DH, Mink LM (1999) Expression of thyroid hormone receptor isoforms in rat growth plate cartilage in vivo. J Bone Miner Res 14(9):1550\u20131556. https:\/\/doi.org\/10.1359\/jbmr.1999.14.9.1550","journal-title":"J Bone Miner Res"},{"issue":"6","key":"314_CR11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s002230001171","volume":"67","author":"K Banovac","year":"2000","unstructured":"Banovac K, Koren E (2000) Triiodothyronine stimulates the release of membrane-bound alkaline phosphatase in osteoblastic cells. Calcif Tissue Int 67(6):460\u2013465","journal-title":"Calcif Tissue Int"},{"issue":"11","key":"314_CR12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1359\/jbmr.090505","volume":"24","author":"MJ Barahona","year":"2009","unstructured":"Barahona MJ, Sucunza N, Resmini E et al (2009) Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing\u2019s syndrome. J Bone Miner Res 24(11):1841\u20131846","journal-title":"J Bone Miner Res"},{"issue":"2-3","key":"314_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","volume":"120","author":"U Baschant","year":"2010","unstructured":"Baschant U, Tuckermann J (2010) The role of the glucocorticoid receptor in inflammation and immunity. J Steroid Biochem Mol Biol 120(2-3):69\u201375","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"314_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1210\/en.2005-0485","volume":"147","author":"JH Bassett","year":"2006","unstructured":"Bassett JH, Swinhoe R, Chassande O, Samarut J, Williams GR (2006) Thyroid hormone regulates heparan sulfate proteoglycan expression in the growth plate. Endocrinology 147(1):295\u2013305. https:\/\/doi.org\/10.1210\/en.2005-0485","journal-title":"Endocrinology"},{"issue":"8","key":"314_CR15","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","volume":"16","author":"S Beavan","year":"2001","unstructured":"Beavan S, Horner A, Bord S et al (2001) Colocalization of glucocorticoid and mineralocorticoid receptors in human bone. J Bone Miner Res 16(8):1496\u20131504","journal-title":"J Bone Miner Res"},{"issue":"4","key":"314_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1210\/jcem.82.4.3853","volume":"82","author":"M Behr","year":"1997","unstructured":"Behr M, Ramsden DB, Loos U (1997) Deoxyribonucleic acid binding and transcriptional silencing by a truncated c-erbA beta 1 thyroid hormone receptor identified in a severely retarded patient with resistance to thyroid hormone. J Clin Endocrinol Metab 82(4):1081\u20131087. https:\/\/doi.org\/10.1210\/jcem.82.4.3853","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"314_CR17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11657-015-0244-1","volume":"10","author":"ZE Belaya","year":"2015","unstructured":"Belaya ZE, Hans D, Rozhinskaya LY et al (2015) The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing\u2019s syndrome. Arch Osteoporos 10(1):44","journal-title":"Arch Osteoporos"},{"key":"314_CR18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/bonekey.2016.42","volume":"5","author":"ZE Belaya","year":"2016","unstructured":"Belaya ZE, Iljin AV, Melnichenko GA et al (2016) Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing\u2019s syndrome. BoneKey Rep 5:815","journal-title":"BoneKey Rep"},{"issue":"4","key":"314_CR19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/endo-115-4-1577","volume":"115","author":"A Bennett","year":"1984","unstructured":"Bennett A, Chen T, Feldman D et al (1984) Characterization of insulin-like growth factor I receptors on cultured rat bone cells: regulation of receptor concentration by glucocorticoids. Endocrinology 115(4):1577\u20131583","journal-title":"Endocrinology"},{"issue":"1","key":"314_CR20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jc.2015-1860","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Watts NB, Usiskin K, Polidori D, Fung A, Sullivan D, Rosenthal N (2016) Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin. J Clin Endocrinol Metab 101(1):44\u201351","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"314_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1110296","volume":"366","author":"E Bochukova","year":"2012","unstructured":"Bochukova E, Schoenmakers N, Agostini M, Schoenmakers E, Rajanayagam O, Keogh JM, Henning E, Reinemund J, Gevers E, Sarri M, Downes K, Offiah A, Albanese A, Halsall D, Schwabe JW, Bain M, Lindley K, Muntoni F, Vargha-Khadem F, Dattani M, Farooqi IS, Gurnell M, Chatterjee K (2012) A mutation in the thyroid hormone receptor alpha gene. N Engl J Med 366(3):243\u2013249. https:\/\/doi.org\/10.1056\/NEJMoa1110296","journal-title":"N Engl J Med"},{"issue":"2","key":"314_CR22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/dom.12189","volume":"16","author":"J Bolinder","year":"2014","unstructured":"Bolinder J, Ljunggren O, Johansson L, Wilding J, Langkilde AM, Sjostrom CD et al (2014) Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin. Diabetes Obes Metab 16(2):159\u2013169","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"314_CR23","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1172\/JCI63377","volume":"122","author":"TC Brennan-Speranza","year":"2012","unstructured":"Brennan-Speranza TC, Henneicke H, Gasparini SJ et al (2012) Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest 122(11):4172\u20134189","journal-title":"J Clin Invest"},{"issue":"8","key":"314_CR24","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA et al (2017) 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid induced osteoporosis. Arthritis Rheumatol 69(8):1521\u20131537","journal-title":"Arthritis Rheumatol"},{"issue":"52","key":"314_CR25","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1556\/oh.2008.28518","volume":"149","author":"B Buday","year":"2008","unstructured":"Buday B, Kulcs\u00e1r E, Liter\u00e1ti Nagy B, Horv\u00e1th T, Vitai M, Vecsei I, Bezzegh K, Kiss J, P\u00e9terfai E, Koltay L, Kor\u00e1nyi L (2008) The role of osteocalcin in the connection of bone and glucose metabolism in humans. Orv Hetil 149(52):2453\u20132461","journal-title":"Orv Hetil"},{"issue":"2","key":"314_CR26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12020-017-1380-8","volume":"59","author":"V Camozzi","year":"2018","unstructured":"Camozzi V, Betterle C, Frigo AC et al (2018) Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison\u2019s disease on glucocorticoid and mineralocorticoid replacement therapy. Endocrine 59(2):319\u2013329","journal-title":"Endocrine"},{"issue":"5","key":"314_CR27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s001980070114","volume":"11","author":"MM Campos Pastor","year":"2000","unstructured":"Campos Pastor MM, L\u00f3pez-Ibarra PJ, Escobar-Jim\u00e9nez F, Serrano Pardo MD, Garc\u00eda-Cervig\u00f3n AG (2000) Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int 11(5):455\u2013459","journal-title":"Osteoporos Int"},{"key":"314_CR28","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A et al (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319\u20131328","journal-title":"Osteoporos Int"},{"issue":"9","key":"314_CR29","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1128\/MCB.11.9.4490","volume":"11","author":"M Centrella","year":"1991","unstructured":"Centrella M, McCarthy TL, Canalis E (1991) Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11(9):4490\u20134496","journal-title":"Mol Cell Biol"},{"issue":"2","key":"314_CR30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00223-016-0203-x","volume":"100","author":"M Chandran","year":"2017","unstructured":"Chandran M (2017) Diabetes drug effects on the skeleton. Calcif Tissue Int 100(2):133\u2013149","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"314_CR31","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","volume":"93","author":"K Chapman","year":"2013","unstructured":"Chapman K, Holmes M, Seckl J (2013) 11b-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev 93(3):1139\u20131206","journal-title":"Physiol Rev"},{"issue":"9","key":"314_CR32","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1210\/mend.11.9.9972","volume":"11","author":"O Chassande","year":"1997","unstructured":"Chassande O, Fraichard A, Gauthier K, Flamant F, Legrand C, Savatier P, Laudet V, Samarut J (1997) Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Mol Endocrinol 11(9):1278\u20131290. https:\/\/doi.org\/10.1210\/mend.11.9.9972","journal-title":"Mol Endocrinol"},{"issue":"6","key":"314_CR33","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00223-014-9847-6","volume":"94","author":"F Chen","year":"2014","unstructured":"Chen F, Zhang L, OuYang Y (2014) Glucocorticoid induced osteoblast apoptosis by increasing E4BP4 expression via up-regulation of Bim. Calcif Tissue Int 94(6):640\u2013647","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"314_CR34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jbmr.2729","volume":"31","author":"S Chen","year":"2016","unstructured":"Chen S, Villalta SA, Agrawal DK (2016) FOXO1 mediates vitamin D deficiency-induced insulin resistance in skeletal muscle. J Bone Miner Res 31(3):585\u2013595","journal-title":"J Bone Miner Res"},{"issue":"6","key":"314_CR35","first-page":"1863","volume":"83","author":"I Chiodini","year":"1998","unstructured":"Chiodini I, Carnevale V, Torlontano M et al (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 83(6):1863\u20131867","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"314_CR36","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/jc.2009-0468","volume":"94","author":"I Chiodini","year":"2009","unstructured":"Chiodini I, Morelli V, Masserini B et al (2009) Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study. J Clin Endocrinol Metab 94(9):3207\u20133214","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"314_CR37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s001980050232","volume":"10","author":"JO Christensen","year":"1999","unstructured":"Christensen JO, Svendsen OL (1999) Bone mineral in pre- and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus. Osteoporos Int 10(4):307\u2013311","journal-title":"Osteoporos Int"},{"issue":"3","key":"314_CR38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","volume":"129","author":"GP Chrousos","year":"1998","unstructured":"Chrousos GP, Torpy DJ, Gold PW (1998) Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 129(3):229\u2013240","journal-title":"Ann Intern Med"},{"key":"314_CR39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2016.08.024","volume":"93","author":"HH Conaway","year":"2016","unstructured":"Conaway HH, Henning P, Lie A, Tuckermann J et al (2016) Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity. Bone 93:43\u201354","journal-title":"Bone"},{"issue":"3","key":"314_CR40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(00)00344-6","volume":"27","author":"MS Cooper","year":"2000","unstructured":"Cooper MS, Walker EA, Bland R et al (2000) Expression and functional consequences of 11b-hydroxysteroid dehydrogenase activity in human bone. Bone 27(3):375\u2013381","journal-title":"Bone"},{"issue":"8","key":"314_CR41","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2003-022025","volume":"88","author":"MS Cooper","year":"2003","unstructured":"Cooper MS, Blumsohn A, Goddard PE et al (2003) 11b-Hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone. J Clin Endocrinol Metab 88(8):3874\u20133877","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"314_CR42","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2265.2005.02281.x","volume":"62","author":"MS Cooper","year":"2005","unstructured":"Cooper MS, Syddall HE, Fall CH et al (2005) Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study. Clin Endocrinol (Oxf) 62(6):692\u2013697","journal-title":"Clin Endocrinol (Oxf)"},{"key":"314_CR43","first-page":"137","volume":"50","author":"HW Cushing","year":"1932","unstructured":"Cushing HW (1932) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137\u2013195","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"5","key":"314_CR44","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","volume":"34","author":"SL Dallas","year":"2013","unstructured":"Dallas SL, Prideaux M, Bonewald LF (2013) The osteocyte: an endocrine cell ... and more. Endocr Rev 34(5):658\u2013690","journal-title":"Endocr Rev"},{"issue":"1","key":"314_CR45","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","volume":"56","author":"F de Vries","year":"2007","unstructured":"de Vries F, Bracke M, Leufkens HG et al (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56(1):208\u2013214","journal-title":"Arthritis Rheum"},{"issue":"9","key":"314_CR46","first-page":"3058","volume":"84","author":"E Dennison","year":"1999","unstructured":"Dennison E, Hindmarsh P, Fall C et al (1999) Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 84(9):3058\u20133063","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"314_CR47","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archinternmed.2009.214","volume":"169","author":"CR Dormuth","year":"2009","unstructured":"Dormuth CR, Carney G, Carleton B, Bassett K, Wright JM (2009) Thiazolidinediones and fractures in men and women. Arch Intern Med 169(15):1395\u20131402","journal-title":"Arch Intern Med"},{"issue":"10","key":"314_CR48","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/jbmr.1648","volume":"27","author":"C Eller-Vainicher","year":"2013","unstructured":"Eller-Vainicher C, Morelli V, Ulivieri FM et al (2013) Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism. J Bone Miner Res 27(10):2223\u20132230","journal-title":"J Bone Miner Res"},{"key":"314_CR49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889\u2013895","journal-title":"Science"},{"issue":"12","key":"314_CR50","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1210\/jc.2007-0744","volume":"92","author":"H Falhammar","year":"2007","unstructured":"Falhammar H, Filipsson H, Holmdahl G et al (2007) Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J Clin Endocrinol Metab 92(12):4643\u20134649","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"314_CR51","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","volume":"50","author":"L Fardet","year":"2011","unstructured":"Fardet L, Petersen I, Nazareth I (2011) Prevalence of longterm oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatology (Oxford) 50(11):1982\u20131990","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"314_CR52","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"Fassnacht M, Arlt W, Bancos I et al (2016) Management of adrenal incidentalomas: European Society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur J Endocrinol 175(2):G1\u2013G34","journal-title":"Eur J Endocrinol"},{"issue":"13","key":"314_CR53","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.steroids.2012.08.014","volume":"77","author":"K Feldman","year":"2012","unstructured":"Feldman K, Szappanos A, Butz H et al (2012) The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women. Steroids 77(13):1345\u20131351","journal-title":"Steroids"},{"issue":"3","key":"314_CR54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","volume":"447","author":"T Fumoto","year":"2014","unstructured":"Fumoto T, Ishii KA, Ito M et al (2014) Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem Biophys Res Commun 447(3):407\u2013412","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"314_CR55","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00198-007-0514-x","volume":"19","author":"L F\u00fct\u0151","year":"2008","unstructured":"F\u00fct\u0151 L, Toke J, Pat\u00f3cs A et al (2008) Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing\u2019s syndrome. Osteoporos Int 19(7):941\u2013949","journal-title":"Osteoporos Int"},{"issue":"4","key":"314_CR56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","volume":"34","author":"LL Gathercole","year":"2013","unstructured":"Gathercole LL, Lavery GG, Morgan SA et al (2013) 11b-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocr Rev 34(4):525\u2013555","journal-title":"Endocr Rev"},{"issue":"3","key":"314_CR57","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/emboj\/18.3.623","volume":"18","author":"K Gauthier","year":"1999","unstructured":"Gauthier K, Chassande O, Plateroti M, Roux JP, Legrand C, Pain B, Rousset B, Weiss R, Trouillas J, Samarut J (1999) Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and post-natal development. EMBO J 18(3):623\u2013631. https:\/\/doi.org\/10.1093\/emboj\/18.3.623","journal-title":"EMBO J"},{"key":"314_CR58","doi-asserted-by":"publisher","unstructured":"Gebru Y, Diao TY, Pan H, Mukwaya E, Zhang Y (2013) Potential of RAS inhibition to improve metabolic bone disorders. Biomed Res Int. https:\/\/doi.org\/10.1155\/2013\/932691","DOI":"10.1155\/2013\/932691"},{"issue":"4","key":"314_CR59","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1124\/pr.58.4.2","volume":"58","author":"P Germain","year":"2006","unstructured":"Germain P, Staels B, Dacquet C, Spedding M, Laudet V (2006) Overview of nomenclature of nuclear receptors. Pharmacol Rev 58(4):685\u2013704. https:\/\/doi.org\/10.1124\/pr.58.4.2","journal-title":"Pharmacol Rev"},{"issue":"6","key":"314_CR60","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jbmr.1870","volume":"28","author":"CC Gluer","year":"2013","unstructured":"Gluer CC, Marin F, Ringe JD et al (2013) Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial. J Bone Miner Res 28(6):1355\u20131368","journal-title":"J Bone Miner Res"},{"issue":"2","key":"314_CR61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ecl.2015.02.009","volume":"44","author":"GM Goddard","year":"2015","unstructured":"Goddard GM, Ravikumar A, Levine AC (2015) Adrenal mild hypercortisolism. Endocrinol Metab Clin North Am 44(2):371\u2013379","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"314_CR62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1463-1326.2008.00931.x","volume":"11","author":"A Grey","year":"2009","unstructured":"Grey A (2009) Thiazolidinedione-induced skeletal fragility--mechanisms and implications. Diabetes Obes Metab 11(4):275\u2013284","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"314_CR63","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41598-017-00163-2","volume":"7","author":"Q Guo","year":"2017","unstructured":"Guo Q, Li H, Xu L, Wu S, Sun H, Zhou B (2017) Undercarboxylated osteocalcin reverts insulin resistance induced by endoplasmic reticulum stress in human umbilical vein endothelial cells. Sci Rep 7(1):46","journal-title":"Sci Rep"},{"key":"314_CR64","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1096\/fj.08-106302","volume":"22","author":"Z Hamidouche","year":"2008","unstructured":"Hamidouche Z, Hay\u00a8 E, Vaudin P et al (2008) FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt\/ \u03b2-catenin signaling-dependent Runx2 expression. FASEB J 22:3813\u20133822","journal-title":"FASEB J"},{"issue":"6","key":"314_CR65","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/03009749609065648","volume":"25","author":"M Hansen","year":"1996","unstructured":"Hansen M, Florescu A, Stoltenberg M (1996) Bone loss in rheumatoid arthritis. Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment. Scand J Rheumatol 25(6):367\u2013376","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"314_CR66","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1152\/physrev.00011.2015","volume":"96","author":"K Hartmann","year":"2016","unstructured":"Hartmann K, Koenen M, Schauer S et al (2016) Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev 96(2):409\u2013447","journal-title":"Physiol Rev"},{"issue":"6","key":"314_CR67","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1210\/jcem-72-6-1189","volume":"72","author":"RD Harvey","year":"1991","unstructured":"Harvey RD, McHardy KC, Reid IW, Paterson F, Bewsher PD, Duncan A, Robins SP (1991) Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab 72(6):1189\u20131194. https:\/\/doi.org\/10.1210\/jcem-72-6-1189","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"314_CR68","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2011.06.013","volume":"49","author":"H Henneicke","year":"2011","unstructured":"Henneicke H, Herrmann M, Kalak R et al (2011) Corticosterone selectively targets endocortical surfaces by an osteoblast-dependent mechanism. Bone 49(4):733\u2013742","journal-title":"Bone"},{"issue":"3","key":"314_CR69","first-page":"751","volume":"83","author":"HM Heshmati","year":"1998","unstructured":"Heshmati HM, Riggs BL, Burritt MF et al (1998) Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J Clin Endocrinol Metab 83(3):751\u2013756","journal-title":"J Clin Endocrinol Metab"},{"key":"314_CR70","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","volume":"140","author":"LC Hofbauer","year":"1999","unstructured":"Hofbauer LC, Gori F, Riggs BL et al (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382\u20134389","journal-title":"Endocrinology"},{"key":"314_CR71","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0016-5085(00)70172-7","volume":"118","author":"M Honda","year":"2000","unstructured":"Honda M, Orii F, Ayabe T et al (2000) Expression of glucocorticoid receptor \u03b2 in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 118:859\u2013866","journal-title":"Gastroenterology"},{"issue":"2","key":"314_CR72","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1359\/jbmr.2000.15.2.188","volume":"15","author":"BK Huang","year":"2000","unstructured":"Huang BK, Golden LA, Tarjan G, Madison LD, Stern PH (2000) Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J Bone Miner Res 15(2):188\u2013197. https:\/\/doi.org\/10.1359\/jbmr.2000.15.2.188","journal-title":"J Bone Miner Res"},{"issue":"1","key":"314_CR73","first-page":"144","volume":"83","author":"NA Huizenga","year":"1998","unstructured":"Huizenga NA, Koper JW, de Lange P et al (1998) A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab 83(1):144\u2013151","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"314_CR74","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bone.2009.07.080","volume":"45","author":"JY Hwang","year":"2009","unstructured":"Hwang JY, Lee SH, Kim GS et al (2009) HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia. Bone 45(6):1098\u20131103","journal-title":"Bone"},{"issue":"6","key":"314_CR75","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s001980050180","volume":"9","author":"M Inaba","year":"1999","unstructured":"Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T, Ishimura E, Nakatsuka K, Shioi A, Morii H (1999) Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 9(6):525\u2013531","journal-title":"Osteoporos Int"},{"issue":"1","key":"314_CR76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11657-017-0336-1","volume":"12","author":"S Ishiguro","year":"2017","unstructured":"Ishiguro S, Ito K, Nakagawa S et al (2017) The clinical benefits of denosumab for prophylaxis of steroid-induced osteoporosis in patients with pulmonary disease. Arch Osteoporos 12(1):44","journal-title":"Arch Osteoporos"},{"issue":"2","key":"314_CR77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0026-0495(82)90123-8","volume":"31","author":"B Jastrup","year":"1982","unstructured":"Jastrup B, Mosekilde L, Melsen F, Lund B, Lund B, Sorensen OH (1982) Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism. Metabolism 31(2):126\u2013132","journal-title":"Metabolism"},{"key":"314_CR78","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","volume":"147","author":"D Jia","year":"2006","unstructured":"Jia D, O\u2019Brien CA, Stewart SA (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147:5592\u20135599","journal-title":"Endocrinology"},{"issue":"10","key":"314_CR79","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1096\/fj.11-182519","volume":"25","author":"J Jia","year":"2011","unstructured":"Jia J, Yao W, Guan M et al (2011) Glucocorticoid dose determines osteocyte cell fate. FASEB J 25(10):3366\u20133376","journal-title":"FASEB J"},{"issue":"8","key":"314_CR80","first-page":"491","volume":"15","author":"SG Jones","year":"2009","unstructured":"Jones SG, Momin SR, Good MW, Shea TK, Patric K (2009) Distal upper and lower limb fractures associated with thiazolidinedione use. Am J Manag Care 15(8):491\u2013496","journal-title":"Am J Manag Care"},{"issue":"3","key":"314_CR81","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Johansson H, Oden A et al (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22(3):809\u2013816","journal-title":"Osteoporos Int"},{"issue":"4","key":"314_CR82","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2265.2004.02110.x","volume":"61","author":"H Karga","year":"2004","unstructured":"Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, Pampouras G (2004) Bone mineral density in hyperthyroidism. Clin Endocrinol (Oxf) 61(4):466\u2013472. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02110.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"314_CR83","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/jbmr.5650090214","volume":"9","author":"H Kawaguchi","year":"1994","unstructured":"Kawaguchi H, Pilbeam CC, Woodiel FN, Raisz LG (1994) Comparison of the effects of 3,5,3\u2032-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae. J Bone Miner Res 9(2):247\u2013253. https:\/\/doi.org\/10.1002\/jbmr.5650090214","journal-title":"J Bone Miner Res"},{"issue":"5","key":"314_CR84","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00268-007-9394-7","volume":"32","author":"A Kawamata","year":"2008","unstructured":"Kawamata A, Iihara M, Okamoto T et al (2008) Bone mineral density before and after surgical cure of Cushing\u2019s syndrome due to adrenocortical adenoma: prospective study. World J Surg 32(5):890\u2013896","journal-title":"World J Surg"},{"issue":"2","key":"314_CR85","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.amjmed.2015.09.020","volume":"129","author":"DL Kendler","year":"2016","unstructured":"Kendler DL, Bauer DC, Davison KS et al (2016) Vertebral fractures: clinical importance and management. Am J Med 129(2):221.e1\u2013221.10","journal-title":"Am J Med"},{"key":"314_CR86","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","volume":"116","author":"HJ Kim","year":"2006","unstructured":"Kim HJ, Zhao H, Kitaura H et al (2006) Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116:2152\u20132160","journal-title":"J Clin Invest"},{"key":"314_CR87","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","volume":"3","author":"JR Kirwan","year":"1995","unstructured":"Kirwan JR et al (1995) The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 3:142\u2013147","journal-title":"N Engl J Med"},{"issue":"7 Suppl","key":"314_CR88","doi-asserted-by":"publisher","first-page":"1996S","DOI":"10.1093\/jn\/125.suppl_7.1996S","volume":"125","author":"K Klaushofer","year":"1995","unstructured":"Klaushofer K, Varga F, Glantschnig H, Fratzl-Zelman N, Czerwenka E, Leis HJ, Koller K, Peterlik M (1995) The regulatory role of thyroid hormones in bone cell growth and differentiation. J Nutr 125(7 Suppl):1996S\u20132003S. https:\/\/doi.org\/10.1093\/jn\/125.suppl_7.1996S","journal-title":"J Nutr"},{"issue":"1","key":"314_CR89","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","volume":"97","author":"KR Koetz","year":"2012","unstructured":"Koetz KR, Ventz M, Diederich S et al (2012) Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. J Clin Endocrinol Metab 97(1):85\u201392","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"314_CR90","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cen.12096","volume":"78","author":"KR Koetz","year":"2013","unstructured":"Koetz KR, van Rossum EF, Ventz M et al (2013) BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 78(6):831\u2013837","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"314_CR91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00298788","volume":"50","author":"P Lakatos","year":"1992","unstructured":"Lakatos P, Stern PH (1992) Effects of cyclosporins and transforming growth factor beta 1 on thyroid hormone action in cultured fetal rat limb bones. Calcif Tissue Int 50(2):123\u2013128","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"314_CR92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1210\/jcem.82.1.3641","volume":"82","author":"P Lakatos","year":"1997","unstructured":"Lakatos P, Foldes J, Horvath C, Kiss L, Tatrai A, Takacs I, Tarjan G, Stern PH (1997) Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab 82(1):78\u201381. https:\/\/doi.org\/10.1210\/jcem.82.1.3641","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"314_CR93","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/thy.2000.10.417","volume":"10","author":"P Lakatos","year":"2000","unstructured":"Lakatos P, Foldes J, Nagy Z, Takacs I, Speer G, Horvath C, Mohan S, Baylink DJ, Stern PH (2000) Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism. Thyroid 10(5):417\u2013423. https:\/\/doi.org\/10.1089\/thy.2000.10.417","journal-title":"Thyroid"},{"issue":"2","key":"314_CR94","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/art.10083","volume":"46","author":"RB Landew\u00e9","year":"2002","unstructured":"Landew\u00e9 RB, Boers M, Verhoeven AC et al (2002) COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 46(2):347\u2013356","journal-title":"Arthritis Rheum"},{"issue":"3","key":"314_CR95","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1359\/JBMR.051103","volume":"21","author":"NE Lane","year":"2006","unstructured":"Lane NE, Yao W, Balooch M et al (2006) Glucocorticoid treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res 21(3):466\u2013476","journal-title":"J Bone Miner Res"},{"issue":"5","key":"314_CR96","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015237","volume":"7","author":"K Laugesen","year":"2017","unstructured":"Laugesen K, J\u00f8rgensen JOL, S\u00f8rensen HT et al (2017) Systemic glucocorticoid use in Denmark: a population-based prevalence study. BMJ Open 7(5):e015237","journal-title":"BMJ Open"},{"issue":"2","key":"314_CR97","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-17-0002","volume":"233","author":"S Lee","year":"2017","unstructured":"Lee S, Donh HH (2017) FoxO integration of insulin signaling with glucose and lipid metabolism. J Endocrinol 233(2):R67\u2013R79","journal-title":"J Endocrinol"},{"issue":"3","key":"314_CR98","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M et al (2007a) Endocrine regulation of of energy metabolism by the skeleton. Cell 130(3):456\u2013469","journal-title":"Cell"},{"issue":"3","key":"314_CR99","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (2007b) Endocrine regulation of energy metabolism by the skeleton. Cell 130(3):456\u2013469","journal-title":"Cell"},{"issue":"21","key":"314_CR100","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1001\/archinternmed.2010.424","volume":"170","author":"JS Lee","year":"2010","unstructured":"Lee JS, Buzkova P, Fink HA, Vu J, Carbone L, Chen Z, Cauley J, Bauer DC, Cappola AR, Robbins J (2010) Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 170(21):1876\u20131883. https:\/\/doi.org\/10.1001\/archinternmed.2010.424","journal-title":"Arch Intern Med"},{"issue":"9","key":"314_CR101","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00535-012-0722-9","volume":"48","author":"J Lee","year":"2013","unstructured":"Lee J, Youn K, Choi NK, Lee JH, Kang D, Song HJ, Park BJ (2013) A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate. J Gastroenterol 48(9):1016\u20131022","journal-title":"J Gastroenterol"},{"issue":"1","key":"314_CR102","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","volume":"180","author":"YK Loke","year":"2009","unstructured":"Loke YK, Singh S, Furberg C (2009) Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ 180(1):32\u201339","journal-title":"CMAJ"},{"issue":"4","key":"314_CR103","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/thy.1997.7.561","volume":"7","author":"A Loviselli","year":"1997","unstructured":"Loviselli A, Mastinu R, Rizzolo E, Massa GM, Velluzzi F, Sammartano L, Mela Q, Mariotti S (1997) Circulating telopeptide type I is a peripheral marker of thyroid hormone action in hyperthyroidism and during levothyroxine suppressive therapy. Thyroid 7(4):561\u2013566. https:\/\/doi.org\/10.1089\/thy.1997.7.561","journal-title":"Thyroid"},{"issue":"6","key":"314_CR104","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s004180000152","volume":"113","author":"E Luegmayr","year":"2000","unstructured":"Luegmayr E, Glantschnig H, Varga F, Klaushofer K (2000) The organization of adherens junctions in mouse osteoblast-like cells (MC3T3-E1) and their modulation by triiodothyronine and 1,25-dihydroxyvitamin D3. Histochem Cell Biol 113(6):467\u2013478","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"314_CR105","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00198-013-2352-3","volume":"24","author":"SR Majumdar","year":"2013","unstructured":"Majumdar SR, Morin SN, Lix LM et al (2013) Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study. Osteoporos Int 24(9):2493\u20132498","journal-title":"Osteoporos Int"},{"issue":"1","key":"314_CR106","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ng0598-87","volume":"19","author":"A Mansouri","year":"1998","unstructured":"Mansouri A, Chowdhury K, Gruss P (1998) Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 19(1):87\u201390. https:\/\/doi.org\/10.1038\/ng0598-87","journal-title":"Nat Genet"},{"key":"314_CR107","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bone.2014.07.008","volume":"67","author":"G Mazziotti","year":"2014","unstructured":"Mazziotti G, Maffezzoni F, Doga M et al (2014) Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs. Bone 67:175\u2013180","journal-title":"Bone"},{"issue":"3","key":"314_CR108","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1210\/endo-126-3-1569","volume":"126","author":"TL McCarthy","year":"1990","unstructured":"McCarthy TL, Centrella M, Canalis E (1990) Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology 126(3):1569\u20131575","journal-title":"Endocrinology"},{"issue":"8","key":"314_CR109","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/archinte.168.8.820","volume":"168","author":"C Meier","year":"2008","unstructured":"Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR (2008) Use of thiazolidinediones and fracture risk. Arch Intern Med 168(8):820\u2013825","journal-title":"Arch Intern Med"},{"issue":"9","key":"314_CR110","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jbmr.2497","volume":"30","author":"L Mellibovsky","year":"2015","unstructured":"Mellibovsky L, Prieto-Alhambra D, Mellibovsky F et al (2015) Bone tissue properties measurement by reference point indentation in glucocorticoid-induced osteoporosis. J Bone Miner Res 30(9):1651\u20131656","journal-title":"J Bone Miner Res"},{"issue":"4","key":"314_CR111","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00774-015-0680-4","volume":"34","author":"G Mendonca Monteiro de Barros","year":"2016","unstructured":"Mendonca Monteiro de Barros G, Madeira M, Vieira Neto L, de Paula Paranhos Neto F, Carvalho Mendonca LM, Correa Barbosa Lima I, Corbo R, Fleiuss Farias ML (2016) Bone mineral density and bone microarchitecture after long-term suppressive levothyroxine treatment of differentiated thyroid carcinoma in young adult patients. J Bone Miner Metab 34(4):417\u2013421. https:\/\/doi.org\/10.1007\/s00774-015-0680-4","journal-title":"J Bone Miner Metab"},{"issue":"4","key":"314_CR112","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-4644(19990915)74:4<684::AID-JCB17>3.0.CO;2-Q","volume":"74","author":"M Milne","year":"1999","unstructured":"Milne M, Kang MI, Cardona G, Quail JM, Braverman LE, Chin WW, Baran DT (1999) Expression of multiple thyroid hormone receptor isoforms in rat femoral and vertebral bone and in bone marrow osteogenic cultures. J Cell Biochem 74(4):684\u2013693","journal-title":"J Cell Biochem"},{"issue":"3","key":"314_CR113","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1359\/jbmr.2002.17.3.443","volume":"17","author":"M Miura","year":"2002","unstructured":"Miura M, Tanaka K, Komatsu Y, Suda M, Yasoda A, Sakuma Y, Ozasa A, Nakao K (2002) Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate. J Bone Miner Res 17(3):443\u2013454. https:\/\/doi.org\/10.1359\/jbmr.2002.17.3.443","journal-title":"J Bone Miner Res"},{"key":"314_CR114","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","volume":"31","author":"M Monarni","year":"2008","unstructured":"Monarni M, Cresci B, Coloumbini A, Pala L, Balzi D, Gori F, Chiasserini V, Marchionni N, Rotella CM, Mannucci E (2008) Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care 31:199\u2013203","journal-title":"Diabetes Care"},{"issue":"9","key":"314_CR115","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/jbmr.432","volume":"26","author":"LE Monfoulet","year":"2011","unstructured":"Monfoulet LE, Rabier B, Dacquin R, Anginot A, Photsavang J, Jurdic P, Vico L, Malaval L, Chassande O (2011) Thyroid hormone receptor beta mediates thyroid hormone effects on bone remodeling and bone mass. J Bone Miner Res 26(9):2036\u20132044. https:\/\/doi.org\/10.1002\/jbmr.432","journal-title":"J Bone Miner Res"},{"issue":"11","key":"314_CR116","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1359\/jbmr.1999.14.11.1971","volume":"14","author":"S Mora","year":"1999","unstructured":"Mora S, Weber G, Marenzi K, Signorini E, Rovelli R, Proverbio MC, Chiumello G (1999) Longitudinal changes of bone density and bone resorption in hyperthyroid girls during treatment. J Bone Miner Res 14(11):1971\u20131977. https:\/\/doi.org\/10.1359\/jbmr.1999.14.11.1971","journal-title":"J Bone Miner Res"},{"issue":"7","key":"314_CR117","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1210\/jc.2016-1423","volume":"101","author":"V Morelli","year":"2016","unstructured":"Morelli V, Eller-Vainicher C, Palmieri S et al (2016) Prediction of vertebral fractures in patients with monolateral adrenal incidentalomas. J Clin Endocrinol Metab 101(7):2768\u20132775","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"314_CR118","doi-asserted-by":"crossref","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","volume":"111","author":"SA Morgan","year":"2014","unstructured":"Morgan SA, McCabe EL, Gathercole LL et al (2014) 11b-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A 111(24):E2482\u2013E2491","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"314_CR119","first-page":"56","volume":"86","author":"L Mosekilde","year":"1978","unstructured":"Mosekilde L, Melsen F (1978) Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Pathol Microbiol Scand A 86(1):56\u201362","journal-title":"Acta Pathol Microbiol Scand A"},{"issue":"1","key":"314_CR120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0889-8529(18)30338-4","volume":"19","author":"L Mosekilde","year":"1990","unstructured":"Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19(1):35\u201363","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"314_CR121","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1365-2265.1996.691513.x","volume":"44","author":"H Nakamura","year":"1996","unstructured":"Nakamura H, Mori T, Genma R, Suzuki Y, Natsume H, Andoh S, Kitahara R, Nagasawa S, Nishiyama K, Yoshimi T (1996) Urinary excretion of pyridinoline and deoxypyridinoline measured by immunoassay in hypothyroidism. Clin Endocrinol (Oxf) 44(4):447\u2013451","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"352","key":"314_CR122","doi-asserted-by":"crossref","first-page":"352ra109","DOI":"10.1126\/scitranslmed.aaf9074","volume":"8","author":"M Nixon","year":"2016","unstructured":"Nixon M, Mackenzie SD, Taylor AI et al (2016) ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: a rationale for safer glucocorticoid replacement therapy. Sci Transl Med 8(352):352ra109","journal-title":"Sci Transl Med"},{"key":"314_CR123","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","volume":"145","author":"CA O\u2019Brien","year":"2004","unstructured":"O\u2019Brien CA, Jia D, Plotkin LI (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835\u20131841","journal-title":"Endocrinology"},{"issue":"7","key":"314_CR124","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1210\/me.2002-0296","volume":"17","author":"PJ O\u2019Shea","year":"2003","unstructured":"O\u2019Shea PJ, Harvey CB, Suzuki H, Kaneshige M, Kaneshige K, Cheng SY, Williams GR (2003) A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormone. Mol Endocrinol 17(7):1410\u20131424. https:\/\/doi.org\/10.1210\/me.2002-0296","journal-title":"Mol Endocrinol"},{"issue":"6","key":"314_CR125","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00198-015-3078-1","volume":"26","author":"MA Paggiosi","year":"2015","unstructured":"Paggiosi MA, Peel NF, Eastell R (2015) The impact of glucocorticoid therapy on trabecular bone score in older women. Osteoporos Int 26(6):1773\u20131780","journal-title":"Osteoporos Int"},{"issue":"11","key":"314_CR126","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s00125-015-3722-5","volume":"58","author":"UB Pajvani","year":"2015","unstructured":"Pajvani UB, Accili D (2015) The new biology of diabetes. Diabetologia 58(11):2459\u20132468","journal-title":"Diabetologia"},{"issue":"2","key":"314_CR127","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00223-016-0226-3","volume":"100","author":"A Palermo","year":"2017","unstructured":"Palermo A, D\u2019Onofrio L, Buzzetti R, Manfrini S, Napoli N (2017) Pathophysiology of bone fragility in patients with diabetes. Calcif Tissue Int 100(2):122\u2013132","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"314_CR128","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1210\/jcem.85.3.6457","volume":"85","author":"H Pantazi","year":"2000","unstructured":"Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85(3):1099\u20131106. https:\/\/doi.org\/10.1210\/jcem.85.3.6457","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"314_CR129","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1530\/ERC-12-0079","volume":"19","author":"P Patel","year":"2012","unstructured":"Patel P, Hardy R, Sumathi V et al (2012) Expression of 11b-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments. Endocr Relat Cancer 19(4):589\u2013598","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"314_CR130","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1210\/en.2015-2010","volume":"157","author":"M Pi","year":"2016","unstructured":"Pi M, Kapoor K, Ye R et al (2016) Evidence for osteocalcin binding and activation of GPRC6A in b-cells. Endocrinology 157(5):1866\u20131880","journal-title":"Endocrinology"},{"issue":"5","key":"314_CR131","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000092454","volume":"65","author":"M Polak","year":"2006","unstructured":"Polak M, Legac I, Vuillard E, Guibourdenche J, Castanet M, Luton D (2006) Congenital hyperthyroidism: the fetus as a patient. Horm Res 65(5):235\u2013242. https:\/\/doi.org\/10.1159\/000092454","journal-title":"Horm Res"},{"issue":"9","key":"314_CR132","doi-asserted-by":"crossref","first-page":"M479","DOI":"10.1093\/gerona\/54.9.M479","volume":"54","author":"H Raff","year":"1999","unstructured":"Raff H, Raff JL, Duthie EH et al (1999) Elevated salivary cortisol in the evening in healthy elderly men and women: correlation with bone mineral density. J Gerontol A Biol Sci Med Sci 54(9):M479\u2013M483","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"314_CR133","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","volume":"11","author":"A Rauch","year":"2010","unstructured":"Rauch A, Seitz S, Baschant U et al (2010) Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab 11(6):517\u2013531","journal-title":"Cell Metab"},{"key":"314_CR134","unstructured":"Recklinghausen FDV (1891) Die Fibr\u00f6se oder deformierende Ostitis, die Osteomalazie und die osteoplastische Carzinose in ihren gegenseitigen Beziehungen. Festchrift Rudolf Virchow (German) Berlin: George Reimer, p 1"},{"issue":"3","key":"314_CR135","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1210\/edrv-14-3-348","volume":"14","author":"S Refetoff","year":"1993","unstructured":"Refetoff S, Weiss RE, Usala SJ (1993) The syndromes of resistance to thyroid hormone. Endocr Rev 14(3):348\u2013399. https:\/\/doi.org\/10.1210\/edrv-14-3-348","journal-title":"Endocr Rev"},{"issue":"9671","key":"314_CR136","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","volume":"373","author":"DM Reid","year":"2009","unstructured":"Reid DM, Devogelaer JP, Saag K et al (2009) Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 373(9671):1253\u20131263","journal-title":"Lancet"},{"key":"314_CR137","first-page":"381","volume":"171","author":"E Ritz","year":"1984","unstructured":"Ritz E, Kreusser W, Rambausek M (1984) Effects of glucocorticoids on calcium and phosphate excretion. Adv Exp Med Biol 171:381\u2013397","journal-title":"Adv Exp Med Biol"},{"key":"314_CR138","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrrheum.2009.231","volume":"5","author":"C Rosen","year":"2009","unstructured":"Rosen C (2009) Bone: serotonin, leptin and the central control of bone remodeling. Nat Rev Rheumatol 5:667\u2013668","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"314_CR139","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ et al (1998) Glucocorticoid-Induced Osteoporosis Intervention Study Group. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339(5):292\u2013299","journal-title":"N Engl J Med"},{"issue":"20","key":"314_CR140","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S et al (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357(20):2028\u20132039","journal-title":"N Engl J Med"},{"issue":"9","key":"314_CR141","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.39726","volume":"68","author":"KG Saag","year":"2016","unstructured":"Saag KG, Agnusdei D, Hans D et al (2016) Trabecular bone score in patients with chronic glucocorticoid therapy induced osteoporosis treated with alendronate or teriparatide. Arthritis Rheumatol 68(9):2122\u20132128","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"314_CR142","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-8587(18)30075-5","volume":"6","author":"KG Saag","year":"2018","unstructured":"Saag KG, Wagman RB, Geusens P et al (2018) Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active controlled, double-dummy, non-inferiority study. Lancet Diabetes Endocrinol 6(6):445\u2013454","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"314_CR143","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-15-0977","volume":"174","author":"AS Salcuni","year":"2016","unstructured":"Salcuni AS, Morelli V, Eller Vainicher C et al (2016) Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism. Eur J Endocrinol 174(3):261\u2013269","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"314_CR144","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2169\/internalmedicine.56.7797","volume":"56","author":"M Sawamura","year":"2017","unstructured":"Sawamura M, Komatsuda A, Togashi M et al (2017) Effects of denosumab on bone metabolic markers and bone mineral density in patients treated with glucocorticoids. Intern Med 56(6):631\u2013636","journal-title":"Intern Med"},{"issue":"4","key":"314_CR145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-15-1096","volume":"174","author":"J Schulz","year":"2016","unstructured":"Schulz J, Frey KR, Cooper MS et al (2016) Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency. Eur J Endocrinol 174(4):531\u2013538","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"314_CR146","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2213-8587(15)00283-1","volume":"4","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue VV, Mitchell DM, Rosen CJ et al (2016) Type 2 diabetes and the skeleton: new insights into sweet bones. Lancet Diabetes Endocrinol 4(2):159\u2013173","journal-title":"Lancet Diabetes Endocrinol"},{"key":"314_CR147","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/en.2003-0655","volume":"145","author":"LB Sher","year":"2004","unstructured":"Sher LB, Woitge HW, Adams DJ et al (2004) Transgenic expression of 11\u03b2 -hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145:922\u2013929","journal-title":"Endocrinology"},{"key":"314_CR148","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M","volume":"76","author":"XM Shi","year":"2000","unstructured":"Shi XM, Blair HC, Yang X et al (2000) Tandem repeat of C\/EBP binding sites mediates PPAR2 gene transcription in glucocorticoid-induced adipocyte differentiation. J Cell Biochem 76:518\u2013527","journal-title":"J Cell Biochem"},{"issue":"2","key":"314_CR149","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jbmr.2347","volume":"30","author":"L Shi","year":"2015","unstructured":"Shi L, Sanchez-Guijo A, Hartmann MF et al (2015) Higher glucocorticoid secretion in the physiological range is associated with lower bone strength at the proximal radius in healthy children: importance of protein intake adjustment. J Bone Miner Res 30(2):240\u2013248","journal-title":"J Bone Miner Res"},{"key":"314_CR150","first-page":"141","volume":"52","author":"H Shibata","year":"1997","unstructured":"Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O\u2019Malley BW (1997) Role of co-activators and co-repressors in the mechanism of steroid\/thyroid receptor action. Recent Prog Horm Res 52:141\u2013164; discussion 164\u2013165","journal-title":"Recent Prog Horm Res"},{"issue":"3","key":"314_CR151","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1359\/JBMR.041233","volume":"20","author":"S Sivagurunathan","year":"2005","unstructured":"Sivagurunathan S, Muir MM, Brennan TC et al (2005) Influence of glucocorticoids on human osteoclast generation and activity. J Bone Miner Res 20(3):390\u2013398","journal-title":"J Bone Miner Res"},{"key":"314_CR152","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mce.2005.11.012","volume":"246","author":"IH Song","year":"2006","unstructured":"Song IH, Buttgereit F (2006) Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 246:142\u2013146","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"314_CR153","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/8756-3282(90)90084-C","volume":"11","author":"WA Soskolne","year":"1990","unstructured":"Soskolne WA, Schwartz Z, Goldstein M, Ornoy A (1990) The biphasic effect of triiodothyronine compared to bone resorbing effect of PTH on bone modelling of mouse long bone in vitro. Bone 11(5):301\u2013307","journal-title":"Bone"},{"key":"314_CR154","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/B978-0-12-800174-5.00010-7","volume":"95","author":"PE Squires","year":"2014","unstructured":"Squires PE, Jones PM, Younis MY, Hills CE (2014) The calcium-sensing receptor and beta-cell function. Vitam Horm 95:249\u2013267","journal-title":"Vitam Horm"},{"issue":"12","key":"314_CR155","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1359\/jbmr.2000.15.12.2431","volume":"15","author":"DA Stevens","year":"2000","unstructured":"Stevens DA, Hasserjian RP, Robson H, Siebler T, Shalet SM, Williams GR (2000) Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. J Bone Miner Res 15(12):2431\u20132442. https:\/\/doi.org\/10.1359\/jbmr.2000.15.12.2431","journal-title":"J Bone Miner Res"},{"key":"314_CR156","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/8756-3282(96)00079-8","volume":"18","author":"RP Stolk","year":"1996","unstructured":"Stolk RP, van Daele PL, Pols HA, Burge RH, Hofman A, Birkenh\u00e4ger JC, Lamberts SW, Grobbee DE (1996) Hyperinsulinemia and bone mineral density in an elderly population: the Rotterdam study. Bone 18:545\u2013549","journal-title":"Bone"},{"issue":"6","key":"314_CR157","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","volume":"75","author":"C Strehl","year":"2016","unstructured":"Strehl C, Bijlsma JW, de Wit M et al (2016) Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Ann Rheum Dis 75(6):952\u2013995","journal-title":"Ann Rheum Dis"},{"key":"314_CR158","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/MED.0b013e3282f1cba3","volume":"14","author":"ES Strotmeyer","year":"2007","unstructured":"Strotmeyer ES, Cauley JA (2007) Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diabetes Obes 14:429\u2013435","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"314_CR159","volume":"6","author":"B Sui","year":"2016","unstructured":"Sui B, Hu C, Liao L, Chen Y et al (2016) Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis. Sci Rep 6(1):30186","journal-title":"Sci Rep"},{"issue":"5","key":"314_CR160","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-09-0139","volume":"161","author":"A Svare","year":"2009","unstructured":"Svare A, Nilsen TI, Bjoro T, Forsmo S, Schei B, Langhammer A (2009) Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study. Eur J Endocrinol 161(5):779\u2013786. https:\/\/doi.org\/10.1530\/EJE-09-0139","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"314_CR161","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2265.2009.03528.x","volume":"71","author":"A Szappanos","year":"2009","unstructured":"Szappanos A, Pat\u00f3cs A, T\u00f5ke J et al (2009) BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clin Endocrinol (Oxf) 71(5):636\u2013643","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"314_CR162","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00198-009-0978-y","volume":"21","author":"A Szappanos","year":"2010","unstructured":"Szappanos A, Toke J, Lippai D et al (2010) Bone turnover in patients with endogenous Cushing\u2019s syndrome before and after successful treatment. Osteoporos Int 21(4):637\u2013645","journal-title":"Osteoporos Int"},{"key":"314_CR163","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0009-8981(61)90171-1","volume":"6","author":"JR Tata","year":"1961","unstructured":"Tata JR (1961) The purification of thyroxine-binding globulin and thyroxine-binding prealbumin. Clin Chim Acta 6:819\u2013832","journal-title":"Clin Chim Acta"},{"issue":"1","key":"314_CR164","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj1780139","volume":"178","author":"FM Tomas","year":"1979","unstructured":"Tomas FM, Munro HN, Young VR (1979) Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of NT-methylhistidine. Biochem J 178(1):139\u2013146","journal-title":"Biochem J"},{"issue":"1","key":"314_CR165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12189","volume":"79","author":"M T\u00f3th","year":"2013","unstructured":"T\u00f3th M, Grossman A (2013) Glucocorticoid-induced osteoporosis: lessons from Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 79(1):1\u201311","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"314_CR166","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1210\/jc.2010-2693","volume":"96","author":"T Vadiveloo","year":"2011","unstructured":"Vadiveloo T, Donnan PT, Cochrane L, Leese GP (2011) The thyroid epidemiology, audit, and research study (TEARS): morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96(5):1344\u20131351. https:\/\/doi.org\/10.1210\/jc.2010-2693","journal-title":"J Clin Endocrinol Metab"},{"key":"314_CR167","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40842-018-0060-9","volume":"4","author":"RJ Valderr\u00e1bano","year":"2018","unstructured":"Valderr\u00e1bano RJ, Linares MI (2018) Diabetes mellitus and bone health: epidemiology, etiology and implications for fracture risk stratification. Clin Diabetes Endocrinol 4:9. https:\/\/doi.org\/10.1186\/s40842-018-0060-9","journal-title":"Clin Diabetes Endocrinol"},{"issue":"12","key":"314_CR168","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP van Staa","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L et al (2000a) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39(12):1383\u20131389","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"314_CR169","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP van Staa","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L et al (2000b) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15(6):993\u20131000","journal-title":"J Bone Miner Res"},{"issue":"4","key":"314_CR170","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00223-003-0033-5","volume":"74","author":"F Varga","year":"2004","unstructured":"Varga F, Spitzer S, Klaushofer K (2004) Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype. Calcif Tissue Int 74(4):382\u2013387. https:\/\/doi.org\/10.1007\/s00223-003-0033-5","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"314_CR171","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bbrc.2010.08.022","volume":"402","author":"F Varga","year":"2010","unstructured":"Varga F, Rumpler M, Zoehrer R, Turecek C, Spitzer S, Thaler R, Paschalis EP, Klaushofer K (2010) T3 affects expression of collagen I and collagen cross-linking in bone cell cultures. Biochem Biophys Res Commun 402(2):180\u2013185. https:\/\/doi.org\/10.1016\/j.bbrc.2010.08.022","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"314_CR172","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/105072502760043503","volume":"12","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L (2002) Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16,249 patients. Thyroid 12(5):411\u2013419. https:\/\/doi.org\/10.1089\/105072502760043503","journal-title":"Thyroid"},{"issue":"6","key":"314_CR173","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/105072503322238854","volume":"13","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk--a meta-analysis. Thyroid 13(6):585\u2013593. https:\/\/doi.org\/10.1089\/105072503322238854","journal-title":"Thyroid"},{"issue":"1","key":"314_CR174","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","volume":"146","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Lindholm J, J\u00f8rgensen JO et al (2002) Increased risk of osteoporotic fractures in patients with Cushing\u2019s syndrome. Eur J Endocrinol 146(1):51\u201356","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"314_CR175","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2796.2005.01467.x","volume":"257","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005a) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257(4):374\u2013384","journal-title":"J Intern Med"},{"key":"314_CR176","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00125-005-1786-3","volume":"48","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark I, Moseklide I (2005b) Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1229\u20131299","journal-title":"Diabetologia"},{"key":"314_CR177","volume-title":"Cellular uptake of thyroid hormones","author":"TJ Visser","year":"2000","unstructured":"Visser TJ (2000) In: Feingold KR, Anawalt B, Boyce A et al (eds) Cellular uptake of thyroid hormones. Endotext, South Dartmouth"},{"issue":"7053","key":"314_CR178","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","volume":"313","author":"LJ Walsh","year":"1996","unstructured":"Walsh LJ, Wong CA, Pringle M et al (1996) Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313(7053):344\u2013346","journal-title":"BMJ"},{"key":"314_CR179","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1210\/en.2007-0910","volume":"149","author":"FS Wang","year":"2008","unstructured":"Wang FS, Ko JY, Yeh DW et al (2008) Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology 149:1793\u20131801","journal-title":"Endocrinology"},{"issue":"1","key":"314_CR180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/07435800.2017.1373662","volume":"43","author":"N Wang","year":"2018","unstructured":"Wang N, Xue P, Wu X, Ma J, Wang Y, Li Y (2018) Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients. Endocr Res 43(1):29\u201338","journal-title":"Endocr Res"},{"issue":"1","key":"314_CR181","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","volume":"101","author":"NB Watts","year":"2016","unstructured":"Watts NB, Bilezikian JP, Usiskin K, Edwards R, Desai M, Law G, Meininger G (2016) Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 101(1):157\u2013166","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"314_CR182","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11914-016-0333-0","volume":"14","author":"DR Weber","year":"2016","unstructured":"Weber DR, Schwartz G (2016) Epidemiology of skeletal health in type 1 diabetes. Curr Osteoporos Rep 14(6):327\u2013336","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"314_CR183","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","volume":"102","author":"RS Weinstein","year":"1998","unstructured":"Weinstein RS, Jilka RL, Parfitt AM et al (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102(2):274\u2013282","journal-title":"J Clin Invest"},{"issue":"8","key":"314_CR184","first-page":"2907","volume":"85","author":"RS Weinstein","year":"2000","unstructured":"Weinstein RS, Nicholas RW, Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85(8):2907\u20132912","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"314_CR185","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1128\/mcb.20.22.8329-8342.2000","volume":"20","author":"GR Williams","year":"2000","unstructured":"Williams GR (2000) Cloning and characterization of two novel thyroid hormone receptor beta isoforms. Mol Cell Biol 20(22):8329\u20138342. https:\/\/doi.org\/10.1128\/mcb.20.22.8329-8342.2000","journal-title":"Mol Cell Biol"},{"issue":"6","key":"314_CR186","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/endo.135.6.7988420","volume":"135","author":"GR Williams","year":"1994","unstructured":"Williams GR, Bland R, Sheppard MC (1994) Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling. Endocrinology 135(6):2375\u20132385. https:\/\/doi.org\/10.1210\/endo.135.6.7988420","journal-title":"Endocrinology"},{"issue":"3","key":"314_CR187","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1210\/endo.142.3.8044","volume":"142","author":"H Woitge","year":"2001","unstructured":"Woitge H, Harrison J, Ivkosic A (2001) Cloning and in vitro characterization of a 1(I)-collagen 11b-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoids. Endocrinology 142(3):1341\u20131348","journal-title":"Endocrinology"},{"issue":"1","key":"314_CR188","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JOE-17-0361","volume":"236","author":"CL Wood","year":"2018","unstructured":"Wood CL, Soucek O, Wong SC et al (2018) Animal models to explore the effects of glucocorticoids on skeletal growth and structure. J Endocrinol 236(1):R69\u2013R91","journal-title":"J Endocrinol"},{"issue":"9","key":"314_CR189","volume":"10","author":"J Xiong","year":"2015","unstructured":"Xiong J, Piemontese M, Onal M et al (2015) Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone. PLoS One 10(9):e0138189","journal-title":"PLoS One"},{"issue":"1","key":"314_CR190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/jc.2014-3019","volume":"100","author":"BB Yeap","year":"2015","unstructured":"Yeap BB, Alfonso H, Chubb SA et al (2015) Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab 100(1):63\u201371","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"314_CR191","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ceca.2014.09.005","volume":"56","author":"A Zarain-Herzberg","year":"2014","unstructured":"Zarain-Herzberg A, Garc\u00eda-Rivas G2, Estrada-Avil\u00e9s R (2014) Regulation of SERCA pumps expression in diabetes. Cell Calcium 56(5):302\u2013310","journal-title":"Cell Calcium"},{"key":"314_CR192","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1074\/jbc.M704147200","volume":"283","author":"W Zhang","year":"2008","unstructured":"Zhang W, Yang N, Shi XM (2008) Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem 283:4723\u20134729","journal-title":"J Biol Chem"},{"issue":"6","key":"314_CR193","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00198-015-3077-2","volume":"26","author":"TY Zhu","year":"2015","unstructured":"Zhu TY, Griffith JF, Qin L et al (2015) Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study. Osteoporos Int 26(6):1759\u20131771","journal-title":"Osteoporos Int"},{"issue":"4","key":"314_CR194","doi-asserted-by":"crossref","first-page":"421","DOI":"10.33549\/physiolres.932668","volume":"63","author":"I Zofkov\u00e1","year":"2014","unstructured":"Zofkov\u00e1 I, Matucha P (2014) New insights into the physiology of bone regulation: the role of neurohormones. Physiol Res 63(4):421\u2013427","journal-title":"Physiol Res"}],"container-title":["Handbook of Experimental Pharmacology","Bone Regulators and Osteoporosis Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T15:08:20Z","timestamp":1606576100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030573775","9783030573782"],"references-count":194,"URL":"https:\/\/doi.org\/10.1007\/164_2019_314","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"9 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}